BioScience Health Innovations, Inc.
NOTR
$9.01
-$0.99-9.90%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -82.21% | -24.26% | 238.95% | -39.06% | 32.75% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -- |
| Change in Net Operating Assets | -1,407.50% | 18.37% | -192.45% | 129.28% | -37.12% |
| Cash from Operations | -196.36% | -24.68% | 244.38% | 15.04% | 19.74% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -171.43% | -- | -- | -- | -- |
| Cash from Investing | -171.43% | -- | -- | -- | -- |
| Total Debt Issued | -1.53% | 47.79% | -20.27% | -9.35% | 45.41% |
| Total Debt Repaid | -27.94% | -25.16% | 28.73% | -15.32% | -15.61% |
| Issuance of Common Stock | 264.00% | -- | -100.00% | 600.00% | -79.17% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 176.61% | 887.43% | -115.04% | 261.13% | -58.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 73.96% | 271.18% | -30.80% | 423.25% | -294.87% |